The Cost Analysis of Human Papillomavirus Vaccination Program in Indonesia

被引:0
|
作者
Setiawan, Didik [1 ,2 ,4 ]
Annisa, Andi Nurul [2 ]
Lianawati, Raymond C. W. [2 ]
Hutubessy, Raymond C. W. [3 ]
Yeung, Karene Hoi Ting [3 ]
机构
[1] Univ Muhammadiyah Purwokerto, Fac Pharm, Purwokerto, Central Of Java, Indonesia
[2] Univ Muhammadiyah Purwokerto, Ctr Hlth Econ Studies, Purwokerto, Central of Java, Indonesia
[3] World Hlth Org, Dept Immunizat Vaccines & Biol, Bern, Switzerland
[4] Univ Muhammadiyah Purwokerto, Fac Pharm, Dukuh Waluh St,POB 202, Purwokerto 53182, Central of Java, Indonesia
关键词
cervical cancer; cost; human papillomavirus; vaccine; VACCINES; IMPACT;
D O I
10.1016/j.vhri.2023.01.005
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: This study aimed to analyze and describe the cost of HPV vaccination program in Indonesia.Methods: This study identified the cost-related HPV vaccination program implemented in Makassar, Manado, and Surabaya cities, Indonesia, according to the previous activities performed. Cost information was collected and analyzed in each specific activity for each cost components, using the HPV vaccination module of the World Health Organization Cervical Cancer Prevention and Control Costing tool.Results: According to the Cervical Cancer Prevention and Control Costing tool, the recurrent costs, both financial and eco-nomic costs, dominated the HPV vaccination program costs in Surabaya (US dollars [USD] 264 618; USD 268 724), Makassar (USD 166 852; USD 293 300), and Manado (USD 270 815; USD 270 946), with a total cost of USD 702 285 for financial cost and USD 832 970 for economic cost. Vaccine procurement drives the recurrent cost.Conclusions: The implementation of demonstration program in Surabaya, Makassar, and Manado cities was considerably succeed. Any prediction related to the cost of implementation of HPV vaccination in Indonesia can be calculated and used to advocate regional or national government.
引用
收藏
页码:102 / 108
页数:7
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS ANALYSIS OF HUMAN PAPILLOMAVIRUS VACCINATION PROGRAM IN RUSSIA
    Omelyanovsky, V
    Avxentyeva, M.
    Krysanov, I
    Ivakhnenko, O.
    Goryaynov, S.
    Tsfasman, F. M.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A277 - A278
  • [2] Cost-effectiveness of a bivalent human papillomavirus vaccination program in Japan
    Connelly, Luke B.
    Le, Ha N. D.
    [J]. SEXUAL HEALTH, 2015, 12 (06) : 520 - 531
  • [3] Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands
    Simons, Joost J. M.
    Vida, Nora
    Westra, Tjalke A.
    Postma, Maarten J.
    [J]. VACCINE, 2020, 38 (30) : 4687 - 4694
  • [4] Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands
    de Kok, Inge M. C. M.
    van Ballegooijen, Marjolein
    Habbema, J. Dik F.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (15) : 1083 - 1092
  • [5] A COST-CONSEQUENCE ANALYSIS OF HUMAN PAPILLOMAVIRUS VACCINATION IN ROMANIA
    Preda, A. L.
    Moise, M.
    Van Kriekinge, G.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A631 - A631
  • [6] Re: Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands
    Coupe, Veerle M. H.
    Meijer, Chris J. L. M.
    Berkhof, Johannes
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (05)
  • [7] Evaluation of a postpartum human papillomavirus vaccination program
    Berenson, Abbey B.
    Hirth, Jacqueline M.
    Kuo, Yong-Fang
    Rupp, Richard E.
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [8] Cost of a human papillomavirus vaccination project, Zimbabwe
    Hidle, Anna
    Gwati, Gwati
    Abimbola, Taiwo
    Pallas, Sarah W.
    Hyde, Terri
    Petu, Amos
    McFarland, Deborah
    Manangazira, Portia
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2018, 96 (12) : 834 - 842
  • [9] Evaluation of a Perinatal Human Papillomavirus Vaccination Program
    Maher, Melissa
    Costello, Joanne
    Byrd, Mary
    [J]. NURSING RESEARCH, 2019, 68 (02) : E162 - E162
  • [10] Cost-effectiveness of a male catch-up human papillomavirus vaccination program in the Netherlands
    Simons, Joost J. M.
    Westra, Tjalke A.
    Postma, Maarten J.
    [J]. PREVENTIVE MEDICINE REPORTS, 2022, 28